GlobalData on MSN19h
FDA approves early feasibility study of Valcare’s transcatheter device
The US Food and Drug Administration (FDA) has granted approval for Valcare Medical’s investigational device exemption ...
Healio11h
FDA approves expanded label for Iluvien
The FDA approved an expanded label for Iluvien, which is now indicated for the treatment of chronic noninfectious uveitis ...
Targeted Oncology12h
Kato Breaks Down FDA Approval of Tislelizumab in Esophageal Cancer
Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.
Onlymyhealth2h
FDA Approves First-Ever Myasthenia Gravis Treatment For Children—A Game Changer In Pediatric Care
The FDA has approved Soliris the first-ever treatment for children with generalized myasthenia gravis gMG offering new hope in pediatric neuromuscular care Learn more!
ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...
MedTech Dive8h
Dr. Oz stresses need for faster Medicare coverage of new devices during confirmation hearing
Mehmet Oz, President Trump’s pick to lead the CMS, said Medicare beneficiaries should have quicker access to new medical ...
Renal & Urology News8h
FDA Approves Cortrophin Gel in Prefilled Syringe Presentation
The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.
Bridge Michigan13h
Whitmer vape tax plan would ban most flavors as ‘contraband’
Michigan Gov. Gretchen Whitmer’s plan to tax e-cigarettes would also ban any vape products not approved by the FDA, treating ...
With newborn screening bill, lawmakers can save lives
CT should become the fifth state to add Duchenne to the screening newborns receive, giving parents the early answers they ...
Scientific American14h
Scientist’s Study Led FDA to Ban Red No. 3 Food Dye. Yet He Says It Is Safe
Joseph Borzelleca published a study on the food coloring Red No. 3. The FDA cited his work when banning the additive in ...
Europe Approves Bristol Myers' Cell Therapy Breyanzi For Patients With Certain Type Of Blood Cancer
EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...
MedPage Today on MSN13h
Approved Sickle Cell Drug Fails to Beat Placebo in Trial
Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.